Enanta Pharmaceuticals Ownership | Who Owns Enanta Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Enanta Pharmaceuticals Ownership Summary

Enanta Pharmaceuticals is owned by 103.93% institutional investors, 6.09% insiders. Farallon capital management is the largest institutional shareholder, holding 9.89% of ENTA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.97% of its assets in Enanta Pharmaceuticals shares.

ENTA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Enanta Pharmaceuticals	103.93%	6.09%	-10.02%
Sector	Healthcare Stocks	47.31%	8.01%	44.69%
Industry	Biotech Stocks	45.43%	7.81%	46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Farallon capital management	2.10M	9.89%	$27.17M
Vanguard group	1.93M	9.13%	$25.09M
Blackrock	1.85M	8.72%	$23.96M
Morgan stanley	1.46M	6.88%	$18.89M
Krensavage asset management	1.25M	5.91%	$16.23M
Armistice capital	1.10M	5.17%	$14.22M
Caligan partners lp	1.04M	4.92%	$13.53M
Marshall wace, llp	928.36K	4.38%	$12.04M
Acadian asset management	849.42K	4.01%	$11.01M
Northern trust	845.12K	3.99%	$10.96M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Krensavage asset management	1.25M	7.45%	$16.23M
Caligan partners lp	1.04M	3.16%	$13.53M
Soleus capital management	799.55K	0.91%	$10.37M
Sio capital management	177.00K	0.62%	$2.30M
Tang capital management	300.00K	0.40%	$3.89M
Armistice capital	1.10M	0.18%	$14.22M
Boothbay fund management	483.28K	0.15%	$6.27M
Farallon capital management	2.10M	0.13%	$27.17M
Portland global advisors	33.19K	0.06%	$430.41K
Pdt partners	36.24K	0.04%	$470.07K

Top Buyers

Holder	Shares	% Assets	Change
Soleus capital management	799.55K	0.91%	219.00K
Caligan partners lp	1.04M	3.16%	184.82K
Krensavage asset management	1.25M	7.45%	126.75K
Boothbay fund management	483.28K	0.15%	94.68K
Bank of america corp /de/	595.91K	0.00%	79.55K

Top Sellers

Holder	Shares	% Assets	Change
Morgan stanley	1.46M	0.00%	-588.59K
Assenagon asset management	426.56K	0.01%	-157.10K
Armistice capital	1.10M	0.18%	-140.00K
Northern trust	845.12K	0.00%	-88.24K
Two sigma investments, lp	184.56K	0.01%	-72.75K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	40.70K	0.00%	40.70K	$527.88K
Corebridge financial	10.81K	0.00%	10.81K	$140.17K
Mirae asset global etfs	9.76K	0.00%	9.76K	$126.61K
Srs capital advisors	128.00	0.00%	128.00	$1.66K
Picton mahoney asset management	79.00	-	79.00	$1.00K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-4.00
Innealta capital	-16.00
Allworth financial lp	-86.00
Signaturefd	-163.00
Comerica bank	-333.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	100	-6.54%	22,011,926	-1.25%	103	0.94%	44	4.76%	44	-12.00%
Mar 31, 2024	107	1.90%	22,290,570	11.98%	105	1.18%	42	-22.22%	50	16.28%
Dec 31, 2023	105	-19.85%	19,906,154	-1.08%	94	1.03%	54	-22.86%	43	-2.27%
Sep 30, 2023	131	-1.50%	20,122,617	-0.08%	95	1.05%	70	-9.09%	44	29.41%
Jun 30, 2023	133	-8.90%	20,138,509	1.66%	95	1.08%	77	45.28%	34	-48.48%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	629.60K	2.97%	-
iShares Russell 2000 ETF	524.38K	2.47%	-1.18K
Vanguard Strategic Small-Cap Equity Inv	300.76K	1.42%	30.09K
Vanguard Institutional Extnd Mkt Idx Tr	281.61K	1.33%	-
Columbia Small Cap Value I A	268.43K	1.27%	67.75K
Vanguard VIF Small Co Gr	253.37K	1.20%	-
Fidelity Small Cap Index	203.26K	0.96%	-5.66K
Columbia Small Cap Value I	200.68K	0.95%	200.68K
iShares Russell 2000 Value ETF	188.38K	0.89%	-
UBS (Lux) EF Biotech (USD) P-acc	182.00K	0.86%	-3.20K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 11, 2024	Rottinghaus Scott T.	Chief Medical Officer	Sell	$64.79K
Jul 15, 2024	Rottinghaus Scott T.	Chief Medical Officer	Sell	$91.81K
Jul 12, 2024	Rottinghaus Scott T.	Chief Medical Officer	Sell	$34.16K
Jun 17, 2024	Kieffer Tara Lynn	Chief Product Strategy Officer	Sell	$89.59K
Dec 13, 2023	Vance Terry	-	Sell	$139.49K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	3
2024 Q2	-	1
2024 Q1	-	-
2023 Q4	-	8
2023 Q3	-	-

ENTA Ownership FAQ

Who Owns Enanta Pharmaceuticals?

Enanta Pharmaceuticals shareholders are primarily institutional investors at 103.93%, followed by 6.09% insiders and -10.02% retail investors. The average institutional ownership in Enanta Pharmaceuticals's industry, Biotech Stocks , is 45.43%, which Enanta Pharmaceuticals exceeds.

Who owns the most shares of Enanta Pharmaceuticals?

Enanta Pharmaceuticals’s largest shareholders are Farallon capital management (2.1M shares, 9.89%), Vanguard group (1.93M shares, 9.13%), and Blackrock (1.85M shares, 8.72%). Together, they hold 27.75% of Enanta Pharmaceuticals’s total shares outstanding.

Does Blackrock own Enanta Pharmaceuticals?

Yes, BlackRock owns 8.72% of Enanta Pharmaceuticals, totaling 1.85M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 23.96M$. In the last quarter, BlackRock increased its holdings by 8.46K shares, a 0.46% change.

Who is Enanta Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is Enanta Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 7.45% of its assets in 1.25M Enanta Pharmaceuticals shares, valued at 16.23M$.

Who is the top mutual fund holder of Enanta Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Enanta Pharmaceuticals shares, with 2.97% of its total shares outstanding invested in 629.6K Enanta Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools